Foresight Acquisition (FORE) Short Interest Ratio & Short Volume

Short interest is the volume of Foresight Acquisition shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 47,600 shares of FORE short. 0.15% of Foresight Acquisition's shares are currently sold short. Learn More on Foresight Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.15% of Foresight Acquisition's floating shares are currently sold short.

Foresight Acquisition saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 47,600 shares, an increase of 98.3% from the previous total of 24,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Foresight Acquisition currently has issued a total of 40,363,000 shares. Some of Foresight Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Foresight Acquisition currently has a public float of 32,370,000 shares.

0.15% of Foresight Acquisition's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Foresight Acquisition: DocGo Inc. (10.71%), Talkspace, Inc. (3.05%), GeneDx Holdings Corp. (6.60%), Sharecare, Inc. (4.17%), InnovAge Holding Corp. (1.63%), P3 Health Partners Inc. (4.57%), The Pennant Group, Inc. (1.28%), U.S. Physical Therapy, Inc. (4.11%), iTeos Therapeutics, Inc. (7.43%), Anika Therapeutics, Inc. (5.73%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Kansas City Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

Short selling FORE is an investing strategy that aims to generate trading profit from Foresight Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Foresight Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FORE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FORE, twice per month. The most recent reporting period available is November, 15 2021.